Viking Therapeutics financial statements

바이킹 테라퓨틱스NASDAQ:VKTX · Nasdaq · Healthcare · sector #17
$28.38-3.07%
2026-10-06 close

Viking Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$151M.

Reported results

Viking Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy